ResearcherKobe UniversityNo recent work listed
Ai Kimoto
Matched on OpenAlex author ID A5022295008. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: 1 paper
Papers 2
- Exosomes in ascites from patients with human pancreatic cancer enhance remote metastasis partially through endothelial-mesenchymal transition. Co-author DOI 10.1016/j.pan.2023.04.002↗
- Pancreatic cancer cell-derived exosomes induce epithelial-mesenchymal transition in human pancreatic cancer cells themselves partially via transforming growth … Co-author DOI 10.1007/s00795-022-00321-0↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kumiko Miyashita · 2 shared papers, 2022–2023 · strength 0.33
- Paper Exosomes in ascites from patients with human pancreatic cancer enhance remote metastasis partially through endothelial-… DOI 10.1016/j.pan.2023.04.002↗
- Paper Pancreatic cancer cell-derived exosomes induce epithelial-mesenchymal transition in human pancreatic cancer cells thems… DOI 10.1007/s00795-022-00321-0↗
- Yuichi Hori · 2 shared papers, 2022–2023 · strength 0.33
- Paper Exosomes in ascites from patients with human pancreatic cancer enhance remote metastasis partially through endothelial-… DOI 10.1016/j.pan.2023.04.002↗
- Paper Pancreatic cancer cell-derived exosomes induce epithelial-mesenchymal transition in human pancreatic cancer cells thems… DOI 10.1007/s00795-022-00321-0↗
- Kazuya Shimizu · 2 shared papers, 2022–2023 · strength 0.33
- Paper Exosomes in ascites from patients with human pancreatic cancer enhance remote metastasis partially through endothelial-… DOI 10.1016/j.pan.2023.04.002↗
- Paper Pancreatic cancer cell-derived exosomes induce epithelial-mesenchymal transition in human pancreatic cancer cells thems… DOI 10.1007/s00795-022-00321-0↗
- Fumiya Nakayama · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.